Andrew R. Hyman

Andrew R. Hyman

Corporate Officer/Principal presso Protez Pharmaceuticals, Inc.

Finance
Consumer Services
Health Technology

Profilo

Prior to joining L Capital Partners, Dr. Hyman was a healthcare analyst at Columbus Circle Investors, a long-short equity hedge fund covering large-cap pharmaceuticals, biotechnology and life sciences companies.
He also worked in business development at Celera Genomics Group.
Dr. Hyman completed his Nephrology and Kidney Transplantation Fellowship at the University of Toronto and Cornell University.
He was on staff as the Associate Medical Director of the Kidney-Pancreas Transplant Program at the Toronto General Hospital.
His research interests focused on the prevention of delayed graft function post kidney transplantation and the effects of anti-rejection drugs on growth factor signaling.
He has received two Canadian National Science Research awards and has authored several peer-reviewed publications.
Dr. Hyman holds an M.D.
with Honors from the University of Toronto, a BSc.
with High Distinction from McGill University and an MBA from The Wharton School of the University of Pennsylvania.
Dr. Hyman is currently an active board observer of Protez, Cenerx and ProRhythm.

Posizioni attive di Andrew R. Hyman

SocietàPosizioneInizio
Corporate Officer/Principal -
Tutte le posizioni attive di Andrew R. Hyman

Precedenti posizioni note di Andrew R. Hyman

SocietàPosizioneFine
Analista di Private Equity 30/06/2007
Analyst-Equity -
Analyst-Equity -
Vedi nel dettaglio l'esperienza di Andrew R. Hyman

Formazione di Andrew R. Hyman

McGill University Undergraduate Degree
University of Toronto Doctorate Degree
University of Pennsylvania Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew R. Hyman

Relazioni

7

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private4

Finance

Finance

Health Technology

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Andrew R. Hyman